Scemblix (Asciminib ) 40 mg 60 tab. Generic, Laos

Indication

Asciminib is indicated for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase who have been previously treated with ≥2 tyrosine kinase inhibitors.6,9 It is also indicated in the treatment of Ph+ CML in adult patients with the T315I mutation.6

The drug is also indicated under accelerated approval for the treatment of newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.